SEC Form 4 · accession 0001209191-15-084836
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Angela Wilson
Officer — Chief Financial Officer
Period of report
Dec 10, 2015
Accepted (ET)
Dec 11, 2015 · 8:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 10, 2015 | P | 167 | $15.28 | A | 167 | D | |
| Common Stock | Dec 10, 2015 | P | 76 | $15.31 | A | 243 | D | |
| Common Stock | Dec 10, 2015 | P | 3,022 | $15.33 | A | 3,265 | D |
Table II — derivative securities
No Table II lines on this filing.